Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.
J Nucl Med. 2010 May;51(5):674-81. doi: 10.2967/jnumed.109.065227. Epub 2010 Apr 15.
Imaging with (18)F-FDG PET/CT is able to reveal vascular inflammation, and several studies have shown that increased (18)F-FDG uptake in carotid artery plaques can qualify the degree of atherosclerotic inflammation. However, clinical assessment of acute aortic dissection (AAD) by PET/CT remains largely unexplored. This study aimed to investigate the use of (18)F-FDG PET/CT to predict short- and midterm outcomes in medically controlled AAD patients.
A total of 28 medically treated AAD patients (2 Stanford type A and 26 type B, aged 69.5 +/- 11.6 y) were prospectively studied. All patients were examined by enhanced CT for diagnosis of AAD and underwent serial imaging studies during follow-up. PET/CT images were acquired 50 and 100 min after (18)F-FDG injection in all patients in the acute phase.
Of the 28 patients, 8 who had an unfavorable outcome due to death from rupture (n = 2), surgical repair (n = 4), and progression of dissection (n = 2) were categorized as having unfavorable AAD. The remaining 20 patients were categorized as having favorable AAD. Maximum dissection diameter in the unfavorable group was significantly greater than that in the favorable group (P = 0.0207). On 50-min images, maximal and mean standardized uptake values (SUVs) at maximum aortic dissection sites were significantly greater for the unfavorable group than for the favorable group (all P < 0.01). A stepwise-forward selection procedure demonstrated that the mean SUV at sites of maximum aortic dissection on 50-min images significantly and independently predicted an unfavorable outcome for AAD (P = 0.0171; odds ratio, 7.72; 95% confidence interval, 1.44-41.4; R(2) = 0.2372). A mean SUV greater than 3.029 had significant predictive power, with sensitivity of 75.0%, specificity of 70.0%, a positive predictive value of 50.0%, a negative predictive value of 87.5%, and accuracy of 71.4%.
Greater uptake of (18)F-FDG in AAD was significantly associated with an increased risk for rupture and progression. (18)F-FDG PET/CT may be used to improve AAD patient management, although more studies are still needed to clarify its role in this clinical scenario.
(18)F-FDG PET/CT 成像能够显示血管炎症,多项研究表明,颈动脉斑块中(18)F-FDG 摄取增加可以确定动脉粥样硬化炎症的程度。然而,PET/CT 对急性主动脉夹层(AAD)的临床评估仍在很大程度上未得到探索。本研究旨在探讨(18)F-FDG PET/CT 对经药物治疗的 AAD 患者短期和中期结局的预测价值。
共前瞻性研究了 28 例经药物治疗的 AAD 患者(2 例 Stanford 型 A,26 例 B 型,年龄 69.5±11.6 岁)。所有患者均接受增强 CT 检查以诊断 AAD,并在随访期间进行连续影像学研究。所有患者在急性阶段均于(18)F-FDG 注射后 50 分钟和 100 分钟进行 PET/CT 检查。
28 例患者中,8 例因破裂(n=2)、手术修复(n=4)和夹层进展(n=2)而死亡,这些患者的结局不佳,被归类为不良 AAD。其余 20 例患者的结局良好。不良组的最大夹层直径明显大于良好组(P=0.0207)。在 50 分钟图像上,不良组最大主动脉夹层部位的最大和平均标准化摄取值(SUVs)明显高于良好组(均 P<0.01)。逐步向前选择程序表明,50 分钟图像上最大主动脉夹层部位的平均 SUV 显著且独立地预测 AAD 的不良结局(P=0.0171;优势比,7.72;95%置信区间,1.44-41.4;R²=0.2372)。SUV 平均值大于 3.029 具有显著的预测能力,其敏感性为 75.0%,特异性为 70.0%,阳性预测值为 50.0%,阴性预测值为 87.5%,准确率为 71.4%。
AAD 中(18)F-FDG 摄取的增加与破裂和进展的风险增加显著相关。(18)F-FDG PET/CT 可能用于改善 AAD 患者的管理,尽管仍需要更多的研究来阐明其在这种临床情况下的作用。